These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 14523919)
1. RNA as a drug target: the case of aminoglycosides. Vicens Q; Westhof E Chembiochem; 2003 Oct; 4(10):1018-23. PubMed ID: 14523919 [No Abstract] [Full Text] [Related]
2. Fluorescence-based approach for detecting and characterizing antibiotic-induced conformational changes in ribosomal RNA: comparing aminoglycoside binding to prokaryotic and eukaryotic ribosomal RNA sequences. Kaul M; Barbieri CM; Pilch DS J Am Chem Soc; 2004 Mar; 126(11):3447-53. PubMed ID: 15025471 [TBL] [Abstract][Full Text] [Related]
3. Targeting RNA with small molecules. Tor Y Chembiochem; 2003 Oct; 4(10):998-1007. PubMed ID: 14523917 [No Abstract] [Full Text] [Related]
4. Aminoglycoside-induced reduction in nucleotide mobility at the ribosomal RNA A-site as a potentially key determinant of antibacterial activity. Kaul M; Barbieri CM; Pilch DS J Am Chem Soc; 2006 Feb; 128(4):1261-71. PubMed ID: 16433544 [TBL] [Abstract][Full Text] [Related]
5. A molecular dynamics simulation study of an aminoglycoside/A-site RNA complex: conformational and hydration patterns. Vaiana AC; Westhof E; Auffinger P Biochimie; 2006 Aug; 88(8):1061-73. PubMed ID: 16824662 [TBL] [Abstract][Full Text] [Related]
6. Docking of cationic antibiotics to negatively charged pockets in RNA folds. Hermann T; Westhof E J Med Chem; 1999 Apr; 42(7):1250-61. PubMed ID: 10197968 [TBL] [Abstract][Full Text] [Related]
8. Targeting the HIV trans-activation responsive region--approaches towards RNA-binding drugs. Krebs A; Ludwig V; Boden O; Göbel MW Chembiochem; 2003 Oct; 4(10):972-8. PubMed ID: 14523913 [No Abstract] [Full Text] [Related]
9. 16S ribosomal RNA methylation: emerging resistance mechanism against aminoglycosides. Doi Y; Arakawa Y Clin Infect Dis; 2007 Jul; 45(1):88-94. PubMed ID: 17554708 [TBL] [Abstract][Full Text] [Related]
10. A genetic model to investigate drug-target interactions at the ribosomal decoding site. Hobbie SN; Bruell C; Kalapala S; Akshay S; Schmidt S; Pfister P; Böttger EC Biochimie; 2006 Aug; 88(8):1033-43. PubMed ID: 16690195 [TBL] [Abstract][Full Text] [Related]
11. A-site model RNAs. Hermann T Biochimie; 2006 Aug; 88(8):1021-6. PubMed ID: 16872733 [TBL] [Abstract][Full Text] [Related]
12. The hammerhead ribozyme structure brought in line. Przybilski R; Hammann C Chembiochem; 2006 Nov; 7(11):1641-4. PubMed ID: 16991176 [No Abstract] [Full Text] [Related]
13. Molecular recognition between the ribosomal decoding site and natural or non-natural aminoglycosides. Westhof E Nucleic Acids Symp Ser (Oxf); 2005; (49):59-60. PubMed ID: 17150632 [TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of paromomycin-related heterocycle-substituted aminoglycoside mimetics based on a mass spectrometry RNA-binding assay. Ding Y; Hofstadler SA; Swayze EE; Risen L; Griffey RH Angew Chem Int Ed Engl; 2003 Jul; 42(29):3409-12. PubMed ID: 12888972 [No Abstract] [Full Text] [Related]
15. Saccharide-RNA recognition. Hermann T; Westhof E Biopolymers; 1998; 48(2-3):155-65. PubMed ID: 10333743 [TBL] [Abstract][Full Text] [Related]